for lymphoma (2). In the past decade, we have made significant progress in understanding the biology of acute myeloid leukemia (AML) and ALL, including studying the underlying immune systems at play ...

Adult acute myeloid leukemia treatment (PDQ): health professional version. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;889(9):731-738. Leukemia and ...

The first patient to die was the first patient to try the drug, a 78 year-old man with BPDCN, although the main phase 1 trial is testing the drug in acute myeloid lymphoma. Sourdive said the ...

Ardent value investor Seth Klarman is swapping out shares of search engine juggernaut Alphabet for a relatively unknown ...

However, concerns around the possibility of high-grade AEs remain, given that Lynparza’s label details the possibility of myelodysplastic syndrome or acute myeloid lymphoma. Another critical ...

The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML ...

Symptoms of non-Hodgkin's lymphoma may include painless swelling ... See what to expect with chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, and learn how it's treated.

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

Findings suggest the potential for obe-cel treatment without the need for consolidative SCTObe-cel given as a sole treatment to patients with ...

While there have been exciting advancements in the treatment of B-cell acute lymphoblastic leukemia over the course of the past decade, the treatment of older adults remains a challenge.

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...